Table 1.
Aim: To update previous recommendations for the clinical management of osteoporosis in residential aged care facilities.12 |
Source: The participants included experts in the field of osteoporosis, geriatric medicine, and rehabilitation (n = 5) who acted as moderators of the small groups and as speakers at the plenary sessions. In addition, geriatricians and general practitioners practicing at the residential aged care level (n = 45) from all over Australia acted as participants at the workshops and plenary sessions. |
Methods: A search of peer-reviewed journals was conducted using MEDLINE (1966–15 November 2014). Relevant articles were identified using combinations of the subject headings “osteoporosis,” “nursing homes,” “residential care,” “long-term care,” “fractures,” “fracture prevention,” “calcium,” “vitamin D,” “bisphosphonates,” “antiresorptives,” “denosumab,” “strontium ranelate,” “teriparatide,” “hip protectors,” “falls,” and “falls prevention.” |
Levels of evidence: Articles retrieved were graded according to their level of evidence based on the NHMRC levels of evidence: |
Level I: A systematic review of level II studies |
Level II: A randomized controlled trial |
Level III-1: A pseudorandomized controlled trial (ie, alternate allocation or some other method) |
Level III-2: A comparative study with concurrent controls:
|
Level III-3: A comparative study without concurrent controls:
|
Level IV: Case series with either posttest of pretest/posttest outcomes |
When an NHMRC level of evidence for a clinically relevant aspect of fracture and fall prevention in the aged cared residential setting was lacking, consensus expert opinion (designated evidence V) was applied. |
Final recommendations: Comments from all participants (experts and participants) on the draft position statement were received and considered. Final clinical recommendations were prepared by the small groups and approved at the final plenary. |
NHMRC, National Health and Medical Research Council.